Form D · Other Technology
DEBUT BIOTECHNOLOGY, INC.
San Diego, CA · CIK 0001798639
Offering snapshot reported Nov 22, 2021 · SEC filing
- Reported sold
- $4M Offering amount: $6M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Nov 8, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2021 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
| Aug 5, 2021 | Initial | $22,644,405 | No comparison | Not reported | SEC filing |
| Sep 14, 2020 | Initial | $2,200,000 | No comparison | 7 | SEC filing |
| Jan 6, 2020 | Initial | $2,611,271 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-421935
Source: Form D, filed Nov 22, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Britton | Director, Executive |
| Corinna Chen | Director |
| Cain A. Mc Clary | Director |
| Daniel Phillips | Director |
| Gregory A. Weiss | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
6330 Nancy Ridge Dr. Unit 106
San Diego, CA, 92121
San Diego, CA, 92121